[EN] NECROSIS INHIBITORS<br/>[FR] INHIBITEURS DE NÉCROSE
申请人:NAT INST OF BIOLOG SCIENCES BEIJING
公开号:WO2016101887A1
公开(公告)日:2016-06-30
The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.